BRCA 2016

Blueprint Genetics is attending the Sixth International Symposium on Hereditary Breast and Ovarian Cancer.

Challenges and Opportunities represents a unique opportunity to look at all aspects of breast and ovarian cancer, and in particular the susceptibility genes, BRCA1 and BRCA2, which are responsible for a considerable fraction of early-onset breast cancer.

Topics covered will include the origins, diagnosis and outcome of BRCA-related ovarian cancer, prevention and treatment of HBOC, and new challenges in genetic counseling in the era of panel testing, to name just a few.

Looking forward to meet you there!


Read more about our diagnostics for hereditary breast and ovarian cancer, by clicking here.

Subscribe to our newsletter